Skip to main content

Grafa News and Videos — Page 1143

Grafa Headlines

Latest

Grafa

Agios licenses oral blood disorder drug from Oscotec in $165M deal

Agios Pharmaceuticals (NASDAQ:AGIO) has acquired an exclusive global license for Oscotec's cevidoplenib, an experimental oral treatment for a rare blood disorder, betting the asset can capture up to $1 billion in peak U.S. sales despite recently missing the main goal of a mid-stage trial.

Read more: Agios licenses oral blood disorder drug from Oscotec in $165M deal
Grafa

Moderna and CEPI expand alliance with $50M for new ebola vaccine

Moderna (NASDAQ:MRNA) has expanded its strategic collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of an experimental vaccine targeting the Bundibugyo ebolavirus strain, an aggressive cause of Ebola virus disease for which there are currently no approved or licensed immunizations.

Read more: Moderna and CEPI expand alliance with $50M for new ebola vaccine
Grafa
Oil and Gas

Oil surges past $94 after U.S. strikes Iran and Israel deepens Lebanon incursion

Oil prices climbed sharply in early Asian trading on Monday as a significant escalation of military activity across the Middle East intensified fears of a prolonged disruption to global energy supplies, overshadowing weak economic indicators from China.

Read more: Oil surges past $94 after U.S. strikes Iran and Israel deepens Lebanon incursion

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift